Mette Jørgensen

Ms. Mette Jørgensen

Rigshospitalet, Copenhagen, Hovedstaden, Denmark
orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 March 2014 in Nature
Verified
Journal Article
Closed access
PDF file
TCThe FANTOM Consortium
The FANTOM Consortium
RARobin Andersson
Robin Andersson
CGClaudia Gebhard
Claudia Gebhard
IMIrene Miguel-Escalada
Irene Miguel-Escalada
IHIlka Hoof
Ilka Hoof
ASAlbin Sandelin
Albin Sandelin

14 July 2013 in Nature Structural & Molecular Biology
Verified
Journal Article
Closed access
ENEvgenia Ntini
Evgenia Ntini
AJAino I Järvelin
Aino I Järvelin
JBJette Bornholdt
Jette Bornholdt
YCYun Chen
Yun Chen
MBMette Boyd
Mette Boyd
TJTorben Heick Jensen
Torben Heick Jensen

1 March 2010 in Journal of Cell Biology
Verified
Journal Article
Open access
HBHalfdan Beck
Halfdan Beck
VNViola Nähse
Viola Nähse
MLMarie Sofie Yoo Larsen
Marie Sofie Yoo Larsen
PGPetra Groth
Petra Groth
TCTrevor Clancy
Trevor Clancy
Claus SørensenClaus Sørensen
Claus Sørensen
Maintenance of genome integrity is of critical importance to cells. To identify key regulators of genomic integrity, we screened a human cell line with a kinome small interfering RNA library. WEE1, a major regulator of mitotic entry, and CHK1 were among the genes identified. Both kinases are important negative regulators of CDK1 and -2. Strikingly, WEE1 depletion rapidly induced DNA damage in S phase in newly replicated DNA, which was accompanied by a marked increase in single-stranded DNA. This DNA damage is dependent on CDK1 and -2 as well as the replication proteins MCM2 and CDT1 but not CDC25A. Conversely, DNA damage after CHK1 inhibition is highly dependent on CDC25A. Furthermore, the inferior proliferation of CHK1-depleted cells is improved substantially by codepletion of CDC25A. We conclude that the mitotic kinase WEE1 and CHK1 jointly maintain balanced cellular control of Cdk activity during normal DNA replication, which is crucial to prevent the generation of harmful DNA lesions during replication.

1 May 2011 in Clinical Cancer Research
Verified
Journal Article
Closed access
PDF file
HHHeidi Rye Hudlebusch
Heidi Rye Hudlebusch
ESEric Santoni-Rugiu
Eric Santoni-Rugiu
RSRonald Simon
Ronald Simon
ERElisabeth Ralfkiær
Elisabeth Ralfkiær
HRHenrik Holm Rossing
Henrik Holm Rossing
KHKristian Helin
Kristian Helin
Purpose: Multiple myeloma SET (Suppressor of variegation, Enhancer of zeste, and Trithorax) domain (MMSET) is a histone lysine methyltransferase deregulated in a subgroup of multiple myelomas with the t(4;14)(p16;q32) translocation and poor prognosis. With the aim of understanding, if MMSET can be involved in other types of cancer we investigated the expression of MMSET protein in different types of human tumors. Experimental Design: A monoclonal antibody against MMSET was developed and immunohistochemical staining of tissue microarrays (TMA) containing a large number of tumor samples (n = 3774) and corresponding normal tissues (n = 904) was carried out. Further validations of MMSET expression were carried out on independent, tumor-specific sets of TMAs for urinary bladder (n = 1293) and colon cancer (n = 1206) with corresponding clinicopathological data and long-term follow-up. Results: MMSET protein was highly expressed in different tumor types compared to normal counterparts. Particular frequent and/or high MMSET expression was found in carcinomas of the gastrointestinal tract (stomach, colon, anal canal), small cell lung carcinoma, tumors of the urinary bladder, female genitals, and skin. In bladder cancer, MMSET expression correlated with tumor aggressiveness. In contrast, MMSET expression was associated with good prognostic factors in colon cancer and was more pronounced in early stages of colon carcinogenesis (dysplasias) than in adenocarcinomas. However, colon cancer patients with high MMSET levels showed a worse 5-year survival. Conclusions: Our data suggest that MMSET has a broader role in cancer than previously anticipated, and further analysis might qualify it as a prognostic marker and a target for the development of therapy against several types of cancer. Clin Cancer Res; 17(9); 2919–33. ©2011 AACR.

17 January 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
RARudi Agius
Rudi Agius
CBChristian Brieghel
Christian Brieghel
MAMichael A. Andersen
Michael A. Andersen
APAlexander T. Pearson
Alexander T. Pearson
BLBruno Ledergerber
Bruno Ledergerber
CNCarsten U. Niemann
Carsten U. Niemann
Infections have become the major cause of morbidity and mortality among patients with chronic lymphocytic leukemia (CLL) due to immune dysfunction and cytotoxic CLL treatment. Yet, predictive models for infection are missing. In this work, we develop the CLL Treatment-Infection Model (CLL-TIM) that identifies patients at risk of infection or CLL treatment within 2 years of diagnosis as validated on both internal and external cohorts. CLL-TIM is an ensemble algorithm composed of 28 machine learning algorithms based on data from 4,149 patients with CLL. The model is capable of dealing with heterogeneous data, including the high rates of missing data to be expected in the real-world setting, with a precision of 72% and a recall of 75%. To address concerns regarding the use of complex machine learning algorithms in the clinic, for each patient with CLL, CLL-TIM provides explainable predictions through uncertainty estimates and personalized risk factors.

16 March 2011 in BMC Genomics
Verified
Journal Article
Open access
PDF file
SSSøren F Schmidt
Søren F Schmidt
MJMette Jørgensen
Mette Jørgensen
YCYun Chen
Yun Chen
RNRonni Nielsen
Ronni Nielsen
ASAlbin Sandelin
Albin Sandelin
SMSusanne Mandrup
Susanne Mandrup
Background: The transcription factors peroxisome proliferator activated receptor γ (PPARγ) and CCAAT/enhancer binding protein α (C/EBPα) are key transcriptional regulators of adipocyte differentiation and function. We and others have previously shown that binding sites of these two transcription factors show a high degree of overlap and are associated with the majority of genes upregulated during differentiation of murine 3T3-L1 adipocytes.Results: Here we have mapped all binding sites of C/EBPα and PPARγ in human SGBS adipocytes and compared these with the genome-wide profiles from mouse adipocytes to systematically investigate what biological features correlate with retention of sites in orthologous regions between mouse and human. Despite a limited interspecies retention of binding sites, several biological features make sites more likely to be retained. First, co-binding of PPARγ and C/EBPα in mouse is the most powerful predictor of retention of the corresponding binding sites in human. Second, vicinity to genes highly upregulated during adipogenesis significantly increases retention. Third, the presence of C/EBPα consensus sites correlate with retention of both factors, indicating that C/EBPα facilitates recruitment of PPARγ. Fourth, retention correlates with overall sequence conservation within the binding regions independent of C/EBPα and PPARγ sequence patterns, indicating that other transcription factors work cooperatively with these two key transcription factors.Conclusions: This study provides a comprehensive and systematic analysis of what biological features impact on retention of binding sites between human and mouse. Specifically, we show that the binding of C/EBPα and PPARγ in adipocytes have evolved in a highly interdependent manner, indicating a significant cooperativity between these two transcription factors.